Matthew Perry, Ketamine, and the Line Between Medical Treatment and Misuse
Image courtesy of Getty Images. Used under license.
The Matthew Perry ketamine case is back in the news as the people involved in obtaining, distributing, and administering ketamine to him are sentenced or held accountable through the federal case.
For patients or those considering ketamine treatment, that can bring up understandable concern.
Ketamine is used in medical settings. It is also a controlled substance that can be misused outside medical care. When “ketamine” appears in headlines without enough context, patients may be left wondering whether supervised ketamine therapy is the same thing as what happened to Matthew Perry.
The distinction matters.
Matthew Perry’s death was tragic. It was also not a simple story of “ketamine therapy caused his death.” According to the Los Angeles County Medical Examiner, Perry died from the acute effects of ketamine, with drowning, coronary artery disease, and buprenorphine effects listed as contributing factors. Federal prosecutors later described a criminal distribution case involving ketamine obtained and administered outside legitimate medical treatment.
That is very different from physician-led, medically supervised IV ketamine therapy.
Why this case is back in the news
The Matthew Perry ketamine case has returned to public attention because the people involved in providing, distributing, and administering ketamine to Perry have now been sentenced or otherwise held accountable through the federal case.
In May of 2026, Perry’s former live-in assistant, Kenneth Iwamasa, was sentenced to nearly 3½ years in federal prison. According to the Department of Justice, Iwamasa pleaded guilty to conspiracy to distribute ketamine resulting in death and serious bodily injury, and he was the fifth and final defendant sentenced in connection with Perry’s death.
Earlier in 2026, a North Hollywood drug dealer who sold ketamine that contributed to Perry’s death was sentenced to 15 years in federal prison. Federal prosecutors also charged doctors and other suppliers connected to the case.
Perry’s case involved ketamine obtained and administered outside legitimate clinical care, which is very different from physician-led, monitored IV ketamine therapy in a medical setting.
Ketamine is a commonly used medication
Ketamine is not new. It has been used in medicine for decades, most commonly as an anesthetic. In medical settings, ketamine is administered with attention to dose, patient selection, monitoring, and recovery.
More recently, ketamine has also been used in carefully selected patients for certain mental health and chronic pain conditions. At Vitalitas Denver, ketamine therapy is physician-led, medically supervised, and provided in a clinical setting.
That is very different from unsupervised use, diverted medication, escalating doses, or ketamine obtained outside legitimate medical treatment.
The same medication can have very different risk profiles depending on the context. That is true for many controlled substances used in medicine. The question is not only what medication is being used, but how it is being used, who is supervising it, where it comes from, and what safeguards are in place.
What made Matthew Perry’s situation different?
Public reporting and federal court materials describe a situation that moved outside appropriate medical care.
Perry had reportedly received ketamine infusion therapy for depression and anxiety. But the Medical Examiner noted that the ketamine in his system at death could not be explained by his last supervised treatment, which had occurred more than a week earlier.
Federal prosecutors later described a criminal distribution case involving ketamine obtained and administered outside legitimate treatment. Perry’s assistant admitted to administering ketamine to him without medical training, including on the day Perry died.
In appropriate clinical care, ketamine is not simply handed over without structure. Patients are screened. Medical history is reviewed. Dosing is selected intentionally. Vital signs are monitored. Patients are observed during and after treatment. Follow-up is part of the plan.
Just as importantly, good care includes boundaries. A responsible clinician knows when to proceed, when to pause, when to coordinate with another provider, and when to decline treatment.
The difference between IV ketamine therapy and nonmedical ketamine use
The word “ketamine” can refer to very different situations.
In an appropriate medical setting, IV ketamine therapy is structured. The patient is evaluated before treatment. The dose is controlled. The care team monitors the patient during the experience. Recovery is observed. The patient has a plan for transportation and aftercare.
In nonmedical use, those safeguards are typically absent. The dose is likely unclear or undependable. The source may be unknown or illegal. The person may be alone or in an unsafe environment. Other medications or substances may be involved. There is likely no medical professional present if complications or overdose occur.
This is why the context matters so much.
Ketamine used in a physician-led clinic is not the same as ketamine obtained through a criminal supply chain or administered at home by someone without medical training.
Why supervision matters
Ketamine treatment can create a temporary altered state. Patients may notice changes in perception, body awareness, emotion, time, or the way thoughts move. Dissociation can be part of the therapeutic experience for many patients, and in a supported clinical setting it is something the care team is prepared for.
During treatment, some patients may also feel sleepy, lightheaded, nauseated, or physically unsteady, and vital signs such as blood pressure or heart rate can change. In a medically supervised setting, the care team can monitor the patient, provide reassurance, respond to discomfort, and support recovery before the patient leaves.
The setting also helps protect patients while the medication is active. After ketamine, patients should not drive, swim, bathe alone, use a hot tub, make major decisions, care for children, or be left without appropriate support while they are still impaired.
In Perry’s case, drowning was listed as a contributing factor. That detail is important because it points to a practical safety issue, not a reason to fear medically supervised care. Ketamine and water do not mix. A person under the effects of ketamine should not be in a pool, hot tub, bathtub, or any environment where sedation, altered perception, or impaired coordination could become dangerous.
Ketamine works best inside a comprehensive care model
One of the clearest lessons from this case is that ketamine should not be separated from medical care. The substance itself is only one part of treatment.
In a comprehensive care model, ketamine is accompanied by structure that helps ensure treatment is appropriate, supported, and responsive to the patient’s needs. That includes:
Medical screening
Review of mental health history
Review of current medications
Thoughtful dosing
Monitoring during treatment
Recovery support
Transportation planning
Follow-up
Clear boundaries around frequency and use
Coordination with other providers when appropriate
This is especially important for patients with complex medical histories, substance use history, cardiovascular concerns, psychiatric complexity, or limited support at home. Those factors do not automatically mean ketamine is not an option. They mean the care plan should be thoughtful, individualized, and supervised.
What Vitalitas does differently
At Vitalitas Denver, ketamine therapy is not casual access to a medication. It is a physician-led treatment process.
That means patients are evaluated before treatment. Dosing is individualized. Treatment takes place in a clinical setting. Patients are monitored during care. Recovery is observed before they leave. The team discusses what to expect afterward and how treatment fits into the patient’s broader care plan.
For mental health patients, ketamine may be considered when depression, anxiety, PTSD, OCD, or related symptoms have not responded well enough to standard approaches. For chronic pain patients, ketamine may be evaluated when pain is severe, persistent, or difficult to control.
In both cases, the goal is not simply to administer ketamine. The goal is to provide care that is appropriate, supported, and medically responsible.
What patients should ask before starting ketamine therapy
Patients should feel comfortable asking direct questions before beginning treatment.
Helpful questions include:
Who determines whether I am a candidate?
Is a physician involved in my care?
How is my dose selected?
What monitoring is used during treatment?
Who is present while I am receiving ketamine?
How long will I be observed before I leave?
What should I avoid after treatment?
What happens if I feel distressed or physically uncomfortable?
How will we evaluate whether treatment is helping?
How does this fit with my broader care plan?
What boundaries are in place around frequency and use?
Clear answers matter. Ketamine is helpful for many patients and should be treated as medicine, not as a shortcut, escape, or open-ended self-directed experience.
Reducing fear without ignoring safety
The lesson of Matthew Perry’s death should not be that ketamine has no place in medicine. The lesson should be that ketamine needs the right setting.
Misuse, diversion, unclear dosing, and administration outside legitimate care are different from physician-led, monitored treatment. Patients deserve to understand that difference.
It is possible to take safety seriously without creating fear. It is possible to acknowledge the tragedy of Perry’s death while also recognizing that medically supervised ketamine therapy is a different kind of care.
At Vitalitas Denver, we believe patients deserve both hope and clarity. Ketamine may help some people with treatment-resistant depression, PTSD, anxiety, OCD, chronic pain, and other difficult conditions. But it should be provided with medical judgment, appropriate monitoring, and clear boundaries.
That is what separates treatment from misuse.
Contact Vitalitas Denver
If you are considering ketamine therapy and want to understand whether it may be appropriate for you, Vitalitas Denver provides physician-led evaluation and medically supervised care.
To ask questions or schedule a consultation, contact us.
